Back
Zevra Therapeutics Stock Price Chart
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Buy
67
ZVRA
Zevra Therapeutics
Last Price:
8.55
Seasonality Move:
4.71%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret Loophole- The current trend is moderately bullish and ZVRA is experiencing slight buying pressure.
Zevra Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.66 | Buy |
| 20-day SMA: | 8.42 | Buy |
| 50-day SMA: | 7.91 | Buy |
| 200-day SMA: | 6.22 | Buy |
| 8-day EMA: | 8.71 | Buy |
| 20-day EMA: | 8.42 | Buy |
| 50-day EMA: | 7.93 | Buy |
| 200-day EMA: | 6.56 | Buy |
Zevra Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.28 | Buy |
| Relative Strength Index (14 RSI): | 64.02 | Buy |
| Chaikin Money Flow: | 206771 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.06 - 8.7) | Buy |
| Bollinger Bands (100): | (5.86 - 8.28) | Buy |
Zevra Therapeutics Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Zevra Therapeutics Stock
Is Zevra Therapeutics Stock a Buy?
- Zevra Therapeutics share price is 8.95 while ZVRA 8-day simple moving average is 8.66, which is a Buy signal.
- The stock price of ZVRA is 8.95 while Zevra Therapeutics 20-day SMA is 8.42, which makes it a Buy.
- Zevra Therapeutics 50-day simple moving average is 7.91 while ZVRA share price is 8.95, making it a Buy technically.
- ZVRA stock price is 8.95 and Zevra Therapeutics 200-day simple moving average is 6.22, creating a Buy signal.
ZVRA Technical Analysis vs Fundamental Analysis
Buy
67
Zevra Therapeutics (ZVRA)
is a Buy
Is Zevra Therapeutics a Buy or a Sell?
-
Zevra Therapeutics stock is rated a Buy
The current Zevra Therapeutics [ZVRA] share price is $8.95. The Score for ZVRA is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
Zevra Therapeutics Stock Info
Market Cap:
470.93M
Price in USD:
8.95
Share Volume:
578.96K
Zevra Therapeutics 52-Week Range
52-Week High:
9.04
52-Week Low:
3.89
Buy
67
Zevra Therapeutics (ZVRA)
is a Buy
Zevra Therapeutics Share Price Forecast
-
What is the Zevra Therapeutics stock price today?
The Zevra Therapeutics stock price is 8.95 USD today. -
Will ZVRA stock go up or go down?
Zevra Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Zevra Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Zevra Therapeutics is not overvalued.
Is Zevra Therapeutics Stock a Buy?
- Zevra Therapeutics share price is 8.95 while ZVRA 8-day exponential moving average is 8.71, which is a Buy signal.
- The stock price of ZVRA is 8.95 while Zevra Therapeutics 20-day EMA is 8.42, which makes it a Buy.
- Zevra Therapeutics 50-day exponential moving average is 7.93 while ZVRA share price is 8.95, making it a Buy technically.
- ZVRA stock price is 8.95 and Zevra Therapeutics 200-day simple moving average is 6.56, creating a Buy signal.
Fundamental Analysis of Zevra Therapeutics
Is Zevra Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and an increase next year of $1.26 per share.
Technical Analysis of Zevra Therapeutics
Should I short Zevra Therapeutics stock?
- ZVRA Moving Average Covergence Divergence (MACD) indicator is 0.28, suggesting Zevra Therapeutics is a Buy
- Zevra Therapeutics Relative Strength Index (RSI) is 64.02, which suggest Zevra Therapeutics is overbought
- The Bollinger Bands (25) for Zevra Therapeutics is (8.06 - 8.7), which suggest Zevra Therapeutics is a Buy
- The Bollinger Bands (100) for Zevra Therapeutics is (5.86 - 8.28), which suggest Zevra Therapeutics is a Buy
* Zevra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.